TUSC3 has been reported in a variety of cancers, such as prostate cancer, ovarian cancer, and pancreatic cancer, and its effects on cell proliferation, migration, and invasion have also been validated [6, 7, 23]. Here, TUSC3 is linked to prostate cancer.